Unlock stock picks and a broker-level newsfeed that powers Wall Street.

CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug
CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug · Investor's Business Daily

In This Article:

Shares of CG Oncology catapulted Monday after the biotech unveiled promising results for a J&J-rivaling bladder cancer treatment.